Decoding Disparities in Colorectal Cancer
People of African descent who receive genetic testing have fewer actionable mutations compared with white people—suggesting fewer available treatment options.
Progress Against Cancer
People of African descent who receive genetic testing have fewer actionable mutations compared with white people—suggesting fewer available treatment options.
When Monica Bertagnolli, MD, was appointed director of the National Cancer Institute in 2022, she became the first woman to hold the post. A few months later, she became the first director to publicly...
Awareness of HPV link to cancer has declined, and more frequent COVID-19 boosters authorized for people who are immunocompromised.
Researchers use insights from behavioral economics to encourage taking recommended actions in health care.
New study finds drug combination after surgery helps prevent recurrence in liver cancer patients.
The 2015 approval of an immune checkpoint inhibitor for renal cell carcinoma (RCC) provided a much-needed new treatment option for patients with this disease, which causes almost 14,000 deaths each year, the majority of...
Accumulating research shows lifelong stressors degrade health and increase cancer risk, but exercise might help counteract the impact of stress.
Study finds mRNA vaccine can help prevent cancer recurrence in advanced melanoma patients.
The FDA has approved a new antibody-drug conjugate to treat two types of non-Hodgkin B-cell lymphomas The U.S. Food and Drug Administration (FDA) has approved polatuzumab vedotin-piiq (Polivy), in combination with a rituximab product,...
This is the first modified, donor cord blood–based stem cell therapy approved to reduce time to hematopoietic recovery and infection The U.S. Food and Drug Administration (FDA) approved omidubicel-onlv (Omisirge) for adult and pediatric...
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More